Shenzhen New Industry Biomedical Engineering Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
The Company has recently received two invention patent certificates from the National Intellectual Property Administration of China and three from the Russian Federal Intellectual Property Office. The details of the patents obtained are as follows:
- Invention Name: Soft Material, Container, Liquid Calibration Product, and Detection Reagent Kit Sealed with Sealing Agent
- Chinese Patent Number: ZL202311839145.6
- Patent Holder: Shenzhen New Industry Biomedical Engineering Co., Ltd.
- Inventors: Li Tinghua, Zhang Yun, Yang Ke, Fu Zhirong, Luo Chun, Wang Qian
- Patent Application Date: December 28, 2023
- Authorization Announcement Date: March 6, 2026
The above patent protects technology independently developed by the Company and is applied in the detection reagent kit for dehydroepiandrosterone (DHEA). DHEA is used clinically for the auxiliary diagnosis of conditions such as polycystic ovary syndrome and adrenal hyperplasia. This invention specifically relates to a liquid calibration product for DHEA, which effectively addresses the issue of concentration decline during storage and transportation due to container adsorption, ensuring the accuracy of test results by introducing testosterone as a sealing agent.